European Pricing Platform - Connecting Pricing People

About

Information booklet Download here

The Life Sciences industry is evolving. Unprecedented market changes are pushing manufacturers to seek out new skills and insights and adapt their strategies and business models. Leaders are already investing in building capabilities that will ensure they meet both commercial & strategic objectives and are re-aligning people, functions and governance structures to that effect.   The Annual Pricing and Profit Optimisation Forum is in its 3rd year, and is the only event of its kind dedicated entirely to the Life Sciences industry. Delegates from across the spectrum of pharma, generics and medical technology will again come together to share, discuss and debate the best approaches to optimising pricing and profitability management.

Over 100 new and returning delegates are expected to join us this year in Montreux for a two-day event of the highest calibre with expert industry opinions and experiences, engaging debate and many opportunities to network with colleagues including the fabulous gala dinner and entertainment at .
 

Industry expert presentations and case studies over the 2 days will focus on 4 key themes:

• Balancing Global & Regional Pricing Strategies;
• Channel performance management;
• Financial control and compliance;
• Organization & Change Management.

Who should attend:

If you are a leader in pricing and market access, marketing, sales and key account management, commercial excellence, finance or IT with vested interests in Pricing and Profitability Management then this year’s forum is the surely the #1 opportunity to meet, learn and further your plans and objectives to improve margins and market share for your company.

Free workshop:

Pre-event ½ day workshop: Industry experts and technology evangelists from Model N will be presenting highlights of their industry leading software suite for pharma and medical technology manufacturers, tackling critical challenges.

June 5

* Topics can still be modified
 

June 6

 * Topics can still be modified 

Pre Workshop

Model N Pricing and Profit Optimisation Workshop 

Click here for more information about this Workshop

Delegates attending the 2013 Life Sciences Forum are invited to join a half-day solution workshop - free of charge - from 1-6 pm on the 4^th June at the Suisse Majestic, Montreux, Switzerland.

Industry experts and technology evangelists from Model N will be presenting highlights of their industry leading software suite for pharma and medical technology manufacturers, tackling challenges such as:
 

International reference price management;

Measuring gross net revenue;

Launch planning and optimisation;

Bid and tender management;

Accounting for innovative pricing techniques;

Ensuring good date governance;

Enforcing pricing and margin controls;

Detecting and analysing the effects of parallel trade;

Commercial channel management.

Experience "day-in-the-life" interactive scenarios for Global, Regional and Local Pricing Managers, Finance and Commercial Analysts, Key Account Managers, Sales Operations and Bid Support Teams, Marketeers and Franchise Owners. Click here for information about the speakers.

Discover how the Model N Revenue Management Suite for Life Sciences is helping leading organisations to protect margins, drive volume growth and ensure financial compliance through a combination of industry best practices and breakthrough software technology.

Click here for more information about the Model N Pricing and Profit Optimisation Workshop

Speakers

VISARTIS Healthcare

Raf De Wilde
Associate VP - GMAC United BioSource Corporation

Mr. De Wilde will be a moderator during the two days of the Life Sciences Forum

Biography: Raf De Wilde, Ph. D., is an expert in global pharmaceutical pricing and market access. Raf introduced Health Economics in Johnson & Johnson in 1991 by leading the first J&J HE team and running leadership training programs involving HE key opinion leaders. He is active in global Pricing since the preparation for launch of RISPERDAL, the first atypcial antipsychotic setting the high price for this class; and including VELCADE, noticed for its price premium in EU versus US and the VELCADE Response Scheme in the UK. Raf joined WorldWide Health Economics and Pricing in October 1997 as Senior Director, Pricing. He retired from J&J in December 2010 and is currently active as independent consultant. Raf's expertise and interests cover all aspects of pharmaceutical drug pricing; key account management strategies; primary and secondary market research; forecasting; and new business models for the pharmaceutical industry. He teaches 'Best Practices on Pharmaceutical Pricing' in a 2-day training program at European Pricing Platform.

Michael Schlander
Professor Innovation and Health Care Management - Universities of Ludwigshafen and Heidelberg 

	Speaks on day 1 (June 5th) from 9.15 until 10.00 Session: Europe - Problem child or rising star? Outlook and opportunities for Growth
Biography:  Will be online soon

Nico Kleyn
Strategy Director - Deloitte Consulting

Speaks on day 2 (June 6th) from 13.45 until 14.30 Session: State of the nation for Life Sciences Pricing and Profitability Management

Biography: Nico Kleyn leads the Pricing Center of Excellence within Deloitte's UK & Swiss Consulting practice. He served as Pricing advisor to Life Sciences and Consumer Business leaders for over 12 years. His relevant experience: he acted as pricing advisor for pricing analytics and execution optimization at multiple Medical Devices companies. He developed and led multi-year channel, pricing and sales excellence programs at global Chemical Manufacturer. He also defined pricing strategy and sales force effectiveness program at global Technology Firm: defining new pricing policies and processes, and key sales KPIs. Further, Nico defined and implemented direct Go-To-Market model and sales implementation for High Tech Manufacturer. He also led growth strategy at Global Chemicals Manufacturer with target to grow fivefold in 5 years through adjacent markets and new market entry. At least, he led the design and development of an international pricing and channel improvement program, implemented through a global sales force training across EU, US, APAC & LATAM.

Raymond Almeida
Vice President Strategic Pricing Support & Analytics - Boston Scientific

Speaks on day 2 (June 6th) from 11.15 until 12.00 Session: Who needs pricing and profitability insights?

Madalina Lavinia Preda
European Pricing Supervisor - Corning Life Sciences B.V.  

Speaks on day 1 (June 5th) from 13.45 until 14.30 Session: Building an organisation that can win the pricing battle

Biography:  Mrs. Madalina Lavinia Preda is currently managing the European pricing organization at Corning Life Sciences located in Amsterdam. In her current role, Madalina has focused on developing a pricing organisation that supports the journey to strategic pricing and profitability management. Prior to this, she was a Junior Lecturer with the Department of British and American Studies, University of Craiova. Her previous professional experience includes exchange lecturing programmes with universities in the Netherlands, Germany and France.

Heiko Visarius

Owner - VISARTIS Healthcare GmbH

Speaks on day 1 (June 5th) from 14.30 until 15.15 Session: Current challenges and new business models for a global medtech player. How to drive change?

Biography: Dr. Heiko Visarius is an executive with international experience in the health care sector, especially in the area of medical device technology. A Ph.D. in engineering obtained in the USA and a Swiss/US MBA degree combined with his professional experience allow him to relate to a broad spectrum of business areas, such as sales, marketing, R&D, finance, supply chain and general management. Dr. Heiko Visarius served as CEO of a successful start-up company with an associated exit. Since then, he held various leadership positions with global players of the medical device industry. He had P/L responsibility in Europe for a 3-digit million USD revenue volume in a direct operation. In addition, Dr. Visarius is board member of a start-up company in medical devices, the Swiss Musical Academy and an international business school. He and his family are located in Switzerland.

Julie Spiesser
Global Strategic Senior Pricing Director - Sanofi Aventis

Speaks on day 1 (June 5th) from 15.45 - 16.30 Session: Getting your Global Pricing Management and Governance Structure Right

Olivier Gemoets
Director - INNOCARUS Management & Consulting

Speaks on day 1 (June 5th) from 15.45 until 16.30 Session: Pricing from a different angle: is old school business model to be renewed?

Biography: Mr. Olivier Gemoets is founder of INNOCARUS Management & Consulting, a boutique management consultancy specialized in Strategy implementation, Business Modeling and Change Management. Prior to founding INNOCARUS, Mr. Gemoets has held several Consulting positions within IBM Global Services and MZSG, Malik Management Zentrum St. Gallen, and worked as an independent consultant for 7 years. During these 15 years, he served in various medium and large international firms, both in Switzerland and Europe wide. Through his large cross-industries experience, Mr. Gemoets brings in deep knowledge of Market & Sales strategies, Multi-channel orientation, value based Pricing model and innovative Business Models. Mr. Gemoets has profound Senior Management Expertise which he collected during 7 years of Sales, Marketing, and Business Development activities within an leading international component supplier for Medical, Automotive & Electronics Customers. Fluent in French, German and English, Mr. Gemoets holds a MSc. in Electronics from ETH Zürich and a MBA from HSG.

Nicholas Brandwood 

Sales Support Engineer - Feedback Processi

Thomas K. Hauser

Chief Compliance Officer - Siemens AG  

Speaks on day 2 (June 6th) from 10.00 until 10.45 Session: 3 pillars support a successful compliance program

Biography: Since the beginning of 2010, Chief Compliance Officer of Siemens Healthcare, headquartered in Erlangen, Germany. The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens Healthcare employs some 51,000 employees worldwide and operates around the world. In fiscal year 2012 (to September 30), the Sector posted revenue of 13.6 billion euros and profit of 1.8 billion euros. Prior to that current mission, he was 2,5 years Chief Compliance Officer of Siemens Building Technologies and 2 years regional head of a Siemens Group in Switzerland. Prior to Siemens, Mr. Hauser has been engaged as COO, Business- or Country Manager at international and national companies in the IT and Telecommunication market. Mr. Hauser is certified IPMA Projects Director (Level A) and international IPMA assess or for IPMA Level A and B.

Janice Haigh
Practice Leader, Market Access Europe - Quintiles

Speaks on day 2 (June 6th) from 14.30 until 15.15 (Duo-presentation with Harry MacDivitt - Axia Value Solutions Ltd) Session: Mind the Gap! Aligning Marketing strategy with value-based sales execution

Biography: Janice joined Quintiles Consulting in January 2012 as Practice Leader for Market Access in Europe. From 2006 to December 2011 she was Senior Director Pricing and Market Access for Astellas Pharma Europe. She was responsible for the development and implementation of pricing and market access strategy for new and in-market products, working closely with brand teams and affiliates. Furthermore, she was responsible for all pricing management, analysing effect of price changes on other markets and designed, implemented and managed Astellas's supply chain integrity program which ensured the matching of supply and demand of products in Europe. Before she joined Astellas in 2006, Janice worked in consultancy for 20 years, including almost 10 years at IMS Health/Cambridge Pharma Consultancy. There, she was responsible for leading projects involving pricing, parallel trade, health economics and health policy.

Harry MacDivitt

Director - Axia Value Solutions Ltd

Speaks on day 2 (June 6th) from 14.30 until 15.15 (Duo-presentation with Janice Haigh - Quintiles) Session: Mind the Gap! Aligning Marketing strategy with value-based sales execution

Biography: Harry trained initially research chemist and subsequently in statistics before abandoning science for business! As a chemist, he worked in process manufacturing and in medical diagnostics. He subsequently worked at a number of levels in pharmaceutical, scientific and medical devices and manufacturing in sales, sales management, product management, marketing management and general management in international companies. Harry has investment interests in a medical devices startup and is a director of Axia Value Solutions, a Pricing Consultancy and Training company. He publishes regularly in professional business magazines in value management and strategic pricing, and speaks regularly on these subjects to professional groups. He also delivers training programmes world-wide in Product Management, Value Based Selling, Value Based Pricing and Business Analysis. He is co-author of Value Based Pricing (published in 2011 by McGraw Hill) and of The Challenge of Value. He is a contributor to Innovation in Pricing (scheduled for introduction by Routledge in late 2102) and has a new title in preparation.

In keeping with tradition, this year’s edition will be The Life Sciences pricing and profit optimisation event on mainland Europe! This is a conference where like-minded individuals from across Europe come to connect and share their pricing knowledge with each other.

Practical

Who should attend?:
From Market-leading Life Sciences, Biotechnology, Medtech, pharma, and Bio similar companies:

CxO s , Senior Vice, Presidents, Vice Presidents, Senior Executives, Heads, Directors:
Pricing / Finance / Payer Relations / International Trade & Policy / Business & Corporate Strategy / Parallel Trade / Reimbursement / Commercial Pricing / Pricing Strategists / Market Access
Research & Development / Brand Management / Sales & marketing / Regulatory Affairs / Governmental Affairs / Tendering / Revenue Optimization
Public Affairs / Public Policy / Contracts / Operations /I.T.

Language of the Forum: English

Dates: 

June 4th: Complimentary Model N pre-workshop (free access for Forum attendees)

June 5th and 6th: EPP Life Sciences Forum

Fee 

*EPP Participants receive a 10% reduction
 

Venue: Grand Hôtel Suisse Majéstic	Due to the success of this Forum, we had to book extra rooms at: Hotel Dest Trois Couronnes
Grand Hôtel Suisse Majéstic Avenue des Alpes 45   CH-1820 Montreux | Switzerland T +41 (0) 21 966 33 33   F +41 (0) 21 966 33 00 www.suisse-majestic.com	Rue di'Italie 49  CH 1800 Vevey  Switzerland Tel : +41 21 923 32 00  Fax: +41 21 923 33 99 www.hoteltroiscouronnes.ch
	FREE transportation offered to the forum venue

EPP offers preferred room rates. (Please note: Limited rooms available)

Please contact: britt.dejager@pricingplatform.eu to obtain your preferred rate.    
       

Sponsors

In partnership with:

Model N is the leading provider of Revenue Management solutions to the life sciences and high tech industries. Model N’s holistic approach to revenue management delivers innovative pricing and profit optimization solutions that are vertical-specific and tightly integrated with Model N’s quoting, contract management, trade promotion, and channel management solutions to help companies manage pricing and margins throughout the entire planning, execution, and settlement stages of the revenue lifecycle. With close to 80 leading companies in both industries, which includes in life sciences Amgen, Teva Pharmaceuticals, Abbott, Novartis, Merck, Pfizer, J&J, Medtronic, Boston Scientific, CR Bard, Corning, Eisai, Procter & Gamble Pharmaceuticals and high tech customers including ST Microelectronics, NXP Semiconductors, Nokia, Dell, FCI, Micron, Avago Technology, Cyrus Logic, Texas Instruments, WMWare, ON Semiconductors and many others - no other pricing vendor has the solution breadth or depth of industry experience that Model N brings to the industries it serves. For more details, go to www.modeln.com.

Gold Sponsor

Evening Event/Dinner Sponsor
 

HighPoint Solutions solves the toughest IT challenges facing companies in the highly regulated life sciences and healthcare industries by providing our clients with practical IT strategies and solution implementations and giving them direct access to the people and technology that get things done. Since 2000, our 400 consultants have provided business consulting and technology solutions that continue to deliver business value and competitive advantage to more than 140 clients nationwide.
HighPoint Solutions is headquartered in Plymouth Meeting, PA with additional offices in New York, New Jersey, Boston, Chicago, and California.

Bronze Sponsor
 

Deloitte provides audit, tax, consulting, and financial advisory services to public and private clients spanning multiple industries. With a globally connected network of member firms in more than 150 countries, Deloitte brings world-class capabilities and high-quality service to clients, delivering the insights they need to address their most complex business challenges. Deloitte has in the region of 200,000 professionals, all committed to becoming the standard of excellence.

Media Partners

Medical News Today is the largest independent medical and health news site on the web - with over 5,000,000 monthly unique users it is ranked number one for medical news on Google and Yahoo!. Medical News Today is used by Blue Chip pharmaceutical and health organizations, advertising agencies, PR companies and vertical ad networks to deliver targeted disease/condition and general health campaigns. For more information contact peter@medicalnewstoday.com or visit www.medicalnewstoday.com

Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. 

Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique Partnering Search service and its global network of industry experts to enable companies to identify and engage with appropriate partners around the world.
Pharmalicensing, and its sister service Medical Device Licensing (www.medicaldevicelicensingcom) are actively utilized by over 200,000 industry professionals each month. Pharmalicensing is a division of IP Technology Exchange, Inc.

BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to source core information on specific bio-related topics, to collate relevant data associated with each topic and to point the user to relevant knowledge resources.

FarmavitaR+ is the professional network of regulatory affairs consultants. The company profiled itself to be the top service provider in regulatory affairs, in central-east and south-east Europe. We are employing a few people in Croatia and the network of associates in Czech R, Slovak R., Hungary, Serbia, Bosnia and Herzegovina, Macedonia, Bulgaria, Romania and Turkey.

Farmavita Net is professional community and network of pharmaceutical licensing and business development executives, innovators and researchers. We are managing the marketplace of offers and demand for pharmaceutical Dossiers, know-how and technologies. Members of Farmavita.Net network usually find a number of attractive solutions for business development, alliances, joint ventures, co-development and co-marketing of pharmaceutical products. Farmavita.Net is not just a pure Internet portal. We manage a number of regional associates. We are connecting the dynamic network of few hundreds members / pharmaceutical companies interested in license-in and license-out opportunities.